Učitavanje...

Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan

The angiotensin II type 1 (AT(1)) receptor blocker (ARB) candesartan strongly reduces blood pressure (BP) in patients with hypertension and has been shown to have cardioprotective effects. A new ARB, azilsartan, was recently approved and has been shown to provide a more potent 24-h sustained antihyp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Miura, Shin-ichiro, Okabe, Atsutoshi, Matsuo, Yoshino, Karnik, Sadashiva S, Saku, Keijiro
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3951115/
https://ncbi.nlm.nih.gov/pubmed/23034464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/hr.2012.147
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!